Skip to main content
Vibegron CAS#: 1190389-15-1
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameVibegronIUPAC Name(6S)-N-pyrrolidin-2-yl]methyl]phenyl]-4-oxo-7,8-dihydro-6H-pyrrolopyrimidine-6-carboxamide  Molecular StructureCAS Registry Number 1190389-15-1SynonymsVIBEGRON1190389-15-1KRP-114VGemtesaMK-4618(S)-N-(4-(((2S,5R)-5-((R)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolopyrimidine-6-carboxamideM5TSE03W5UC26H28N4O3Molecular FormulaC26H28N4O3Molecular Weight444.5InChI InChI=1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/t20-,21+,22-,25+/m0/s1  InChI KeyDJXRIQMCROIRCZ-XOEOCAAJSA-N  

Patent InformationPatent IDTitlePublication DateUS2009/253705HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS2009

Physical Data

Spectra

Description (NMR Spectroscopy)Nucleus (NMR Spectroscopy)Solvents (NMR Spectroscopy)Temperature (NMR Spectroscopy), °C Frequency (NMR Spectroscopy), MHzSpectrum1Hdimethylsulfoxide-d626.84400Chemical shifts, Spectrum1Hdimethylsulfoxide-d626.84500COSY (Correlation Spectroscopy), Spectrum1H, 1Hdimethylsulfoxide-d626.84500ROESY (Rotating frame Overhauser Enhancement Spectroscopy), Spectrum1H, 1Hdimethylsulfoxide-d626.84500HSQC (Heteronuclear Single Quantum Coherence), Spectrum1H, 13Cdimethylsulfoxide-d626.84HMBC (Heteronuclear Multiple Bond Coherence), Spectrum1H, 13Cdimethylsulfoxide-d626.84Spectrum13Cdimethylsulfoxide-d626.84126

Route of Synthesis (ROS)

Route of Synthesis (ROS) of vibegron-cas-1190389-15-1

ConditionsYieldStage #1: tert-butyl(2R,5S)-2--5-pyrimidin-6-yl]carbonyl}amino)benzyl]pyrrolidine-1-carboxylate With trifluoroacetic acid In dichloromethane at 20℃; for 1.5h;Stage #2: With sodium hydrogencarbonate pH=8 - 9;60%Stage #1: tert-butyl(2R,5S)-2--5-pyrimidin-6-yl]carbonyl}amino)benzyl]pyrrolidine-1-carboxylate With trifluoroacetic acid In dichloromethane at 20℃; for 1.5h;Stage #2: With sodium hydrogencarbonate pH=8 - 9;60%Experimental ProcedureTo a solution of the intermediate from Step A (2.50 g, 4.59 mmol) in dichloromethane (40 ml) was added trifluoroacetic acid (15 ml). The reaction mixture was stirred at ambient temperature for 1.5 h. After removal of the volatiles, saturated NaHCO3 was added to make the PH value to 8-9. The mixture was then extracted with dichloromethane. The combined organic layers were dried over Na2SO4. After concentration, crystallization from methanol/acetonitrile afforded the title compound as a white solid (1.23 g, 60%). 1H NMR (DMSO-d6): δ 10.40 (s, 1H), 7.91 (d, J=6.7 Hz, 1H), 7.49 (d, J=8.3 Hz, 2H), 7.32-7.26 (m, 4H), 7.21 (m, 1H), 7.15 (d, J=8.4 Hz, 2H), 6.23 (d, J=6.7 Hz, 1H), 5.11 (dd, J=9.6, 2.9 Hz, 1H), 5.10 (br, 1H), 4.21 (d, J=7.1 Hz, 1H), 3.20-3.00 (m, 4H), 2.66-2.51 (m, 3H), 2.16 (m, 1H), 1.57 (m, 1H), 1.38 (m, 1H), 1.29-1.23 (m, 2H). LC-MS 445.3 (M+1).

Safety and Hazards

No data available

Other Data

TransportationUnder the room temperature and away from lightHS CodeStorageUnder the room temperature and away from lightShelf Life1 yearMarket Price

DruglikenessLipinski rules componentMolecular Weight444.533logP1.581HBA7HBD3Matching Lipinski Rules4Veber rules componentPolar Surface Area (PSA)94.03Rotatable Bond (RotB)7Matching Veber Rules2

Quantitative Results1 of 13Comment (Pharmacological Data)Bioactivities presentReferenceHYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS2 of 13Comment (Pharmacological Data)Bioactivities presentReferenceAN AGENT FOR TREATING NOCTURNAL POLLAKIURIA3 of 13Comment (Pharmacological Data)Bioactivities presentReferencePollakiuria night therapeutic agent4 of 13Comment (Pharmacological Data)Bioactivities presentReferenceProcess for preparing beta 3 agonists and intermediates5 of 13 Comment (Pharmacological Data)Bioactivities presentReferenceAgent for treating nocturnal pollakiuria6 of 13Comment (Pharmacological Data)physiological behaviour discussedReferenceSelectivity and Maximum Response of Vibegron and Mirabegron for β3-Adrenergic Receptors7 of 13Comment (Pharmacological Data)physiological behaviour discussedReferenceMETHODS OF TREATING HEART FAILURE WITH VIBEGRON

Toxicity/Safety PharmacologyQuantitative Results

Use PatternVibegron CAS#: 1190389-15-1 is an intermediate in pesticides and dyes; pesticide raw materials; analytical reagents.
https://www.chemwhat.com/vibegron-cas-1190389-15-1/

Comments

Popular posts from this blog

The World's Largest Producer of Squaric Acid Emerges: Watson Leads the Way

In a groundbreaking development for the chemical industry, Watson has officially claimed the title of the world’s largest producer of squaric acid. This achievement marks a significant milestone, positioning the company as a global leader in the production of this highly versatile compound, widely valued in pharmaceuticals, polymer research, and advanced materials. What is Squaric Acid? Squaric acid, also known as quadratic acid, is a four-carbon cyclic diketone with two ketone groups and two hydroxyl groups arranged symmetrically. It is renowned for its stability and strong acidity, making it a unique compound in both organic and inorganic chemistry. Its derivatives find applications in creating advanced coatings, conductive polymers, and as intermediates in drug synthesis. Watson: Redefining Excellence in Squaric Acid Production Watson’s rise to the top of the squaric acid industry is backed by its unmatched production capacity, cutting-edge technology, and unwavering commitment...
Names & IdentifiersProduct NameHYDROXYPROPYL CHITOSANSynonymsN-(2-Hydroxypropyl)chitosanCAS Registry Number104673-29-2Molecular FormulaMolecular Weight0EINECSOther Registry NumbersMore Identifiers on PubChemIUPA Names, InChI, InChI Key, Canonical SMILES, etc.Chemical & Physical Properties Safety & Hazards(Codes & Phrases) More Safety & Hazards From PubChem Signal, GHS Hazard Statements, Precautionary Statement Codes, etc. Literature Literature on PubChem Synthesis References, Metabolite References, etc. Patents Patents on PubChem Related Patents Of This Product Transportation, Storage & Usage Transportation No Information Storage No Information Usage No Information Spectral Properties No Information https://www.chemwhat.com/hydroxypropyl-chitosan-cas-104673-29-2/
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product Namemethylammonium iodideIUPAC Namemethylazanium;iodide Molecular StructureCAS Registry Number 14965-49-2MDL NumberMFCD28100833SynonymsMethylammonium iodide14965-49-2methylazanium;iodideEINECS 239-037-4methylazanium iodideMethanamine, hydriodideMethyl ammonium iodideMethylamine.hydriodicacidSCHEMBL1534750Methylammonium Iodide, anhydrousDB-221235NS00086090Molecular FormulaCH6INMolecular Weight158.97InChIInChI=1S/CH5N.HI/c1-2;/h2H2,1H3;1HInChI KeyLLWRXQXPJMPHLR-UHFFFAOYSA-N  Canonical SMILESC. Patent InformationPatent IDTitlePublication DateWO2023/180219A METHOD FOR SYNTHESIS OF HALIDE SALTS2023CN113845428Preparation method of perovskite material powder2021WO2018/169373METHOD OF PREPARING LUMINESCENT NANO-SHEET, LUMINESCENT NANO-SHEET MATERIAL, LUMINESCENT NANO-SHEET FILM, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY APPARATUS2018WO2015/32748AMORPHOUS MATERIAL AND THE USE THEREOF2018 ...